...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program

Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program

posted on Mar 18, 2019 02:39PM

...and dont forget that cancer seems to be the major focus here in 2019 by BP,,,,,and that the CURATe-AI either cured or put into remission the thought to be incurable prostate cancer!!!!,,Why wouldn't Pfizer buy up the CURATE-AI system and Zenith for this individualized profile care,,,,there is no doubt in my mind that Pfizer is planning their future with such technology front and center!!,,,its an opinion,,,,but it seems to me to be a logical out come.

Share
New Message
Please login to post a reply